PMC Links for Books (Select 4855014) - PMC

Select item 56500961.

Final Analysis of Efficacy and Safety of Omacetaxine Mepesuccinate in Patients With Chronic Phase (CP) or Accelerated Phase (AP) Chronic Myeloid Leukemia (CML): 24-Month Minimum Follow-Up Results

Jorge Cortes, Hagop M. Kantarjian, Delphine Rea, Meir Wetzler, Jeffrey H. Lipton, Luke Akard, H. Jean Khoury, Mauricette Michallet, Agnès Guerci-Bresler, Charles Chuah, Andrzej Hellmann, Raghunadharao Digumarti, Purvish M. Parikh, Laurence Legros, Krzysztof Warzocha, Michele Baccarani, Elizabeth Li, Mihaela Munteanu, Franck E. Nicolini

Cancer. Author manuscript; available in PMC 2017 Oct 20.

Published in final edited form as: Cancer. 2015 May 15; 121(10): 1637–1644. Published online 2015 Jan 13. doi: 10.1002/cncr.29240

PMCID:: PMC5650096

Abstract Article PDF–933K

Select item 55588402.

Phase 2 study of subcutaneous omacetaxine mepesuccinate for chronic-phase chronic myeloid leukemia patients resistant to or intolerant of tyrosine kinase inhibitors

J. Cortes, R. Digumarti, P.M. Parikh, M. Wetzler, J.H. Lipton, A. Hochhaus, A.R. Craig, A.-C. Benichou, F.E. Nicolini, H.M. Kantarjian, the Omacetaxine 203 Study Group

Am J Hematol. Author manuscript; available in PMC 2017 Aug 16.

Published in final edited form as: Am J Hematol. 2013 May; 88(5): 350–354. Published online 2013 Mar 7. doi: 10.1002/ajh.23408

PMCID:: PMC5558840

Abstract Article PDF–288K

Select item 49165833.

Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation

Jorge Cortes, Jeff H. Lipton, Delphine Rea, Raghunadharao Digumarti, Charles Chuah, Nisha Nanda, Annie-Claude Benichou, Adam R. Craig, Mauricette Michallet, Franck E. Nicolini, Hagop Kantarjian

Blood. 2012 Sep 27; 120(13): 2573–2580. Prepublished online 2012 Aug 15. doi: 10.1182/blood-2012-03-415307

PMCID:: PMC4916583

Abstract Article

Select item 44462354.

Features and Outcomes of 899 Patients with Drug-induced Liver Injury: The DILIN Prospective Study

N Chalasani, HL Bonkovsky, R Fontana, W Lee, A Stolz, J Talwalkar, KR Reddy, PB Watkins, V Navarro, H Barnhart, J Gu, J Serrano, for the United States Drug Induced Liver Injury Network

Gastroenterology. Author manuscript; available in PMC 2016 Jun 1.

Published in final edited form as: Gastroenterology. 2015 Jun; 148(7): 1340–1352.e7. Published online 2015 Mar 6. doi: 10.1053/j.gastro.2015.03.006

PMCID:: PMC4446235

Abstract Article PDF–546K

Select item 39030685.

U.S. Food and Drug Administration Approval Summary: Omacetaxine Mepesuccinate as Treatment for Chronic Myeloid Leukemia

Firoozeh Alvandi, Virginia E. Kwitkowski, Chia-Wen Ko, Mark D. Rothmann, Stacey Ricci, Haleh Saber, Debasis Ghosh, Janice Brown, Erika Pfeiler, Elsbeth Chikhale, Joseph Grillo, Julie Bullock, Robert Kane, Edvardas Kaminskas, Ann T. Farrell, Richard Pazdur

Oncologist. 2014 Jan; 19(1): 94–99. Published online 2013 Dec 5. doi: 10.1634/theoncologist.2013-0077

PMCID:: PMC3903068

Abstract Article PDF–642K

Select item 37759656.

Homoharringtonine/Omacetaxine Mepesuccinate: The Long and Winding Road to Food and Drug Administration Approval

Hagop M. Kantarjian, Susan O’Brien, Jorge Cortes

Clin Lymphoma Myeloma Leuk. Author manuscript; available in PMC 2014 Oct 1.

Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2013 Oct; 13(5): 530–533. Published online 2013 Jun 20. doi: 10.1016/j.clml.2013.03.017

PMCID:: PMC3775965

Abstract Article PDF–39K

Select item 37758957.

Subcutaneous Omacetaxine Mepesuccinate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With 2 or More Tyrosine Kinase Inhibitors Including Imatinib

Jorge E. Cortes, Franck E. Nicolini, Meir Wetzler, Jeffrey H. Lipton, Luke Akard, Adam Craig, Nisha Nanda, Annie-Claude Benichou, Janis Leonoudakis, H. Jean Khoury, Andreas Hochhaus, Michele Baccarani, Hagop M. Kantarjian

Clin Lymphoma Myeloma Leuk. Author manuscript; available in PMC 2014 Oct 1.

Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2013 Oct; 13(5): 584–591. Published online 2013 Jun 17. doi: 10.1016/j.clml.2013.03.020

PMCID:: PMC3775895

Abstract Article PDF–333K

Select item 37457818.

A phase II Open-label Study of the Intravenous Administration of Homoharringtonine in the treatment of Myelodysplastic syndrome

Naval Daver, Arturo Vega-Ruiz, Hagop M. Kantarjian, Zeev Estrov, Alessandra Ferrajoli, Steve Kornblau, Srdan Verstovsek, Guillermo Garcia-Manero, Jorge E. Cortes

Eur J Cancer Care (Engl) Author manuscript; available in PMC 2014 Sep 1.

Published in final edited form as: Eur J Cancer Care (Engl). 2013 Sep; 22(5): 605–611. Published online 2013 May 23. doi: 10.1111/ecc.12065

PMCID:: PMC3745781

Abstract Article PDF–49K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from Books

Items: 8

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity